The pursuit of an ideal family care pharmacist -To overcome the pharmacist crisis in Japan-
date : 7/19/2015
The pursuit of an ideal family care pharmacist
-To overcome the pharmacist crisis in Japan-
Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin-top:0mm; mso-para-margin-right:0mm; mso-para-margin-bottom:0mm; mso-para-margin-left:21.0pt; mso-para-margin-bottom:.0001pt; text-indent:-21.0pt; line-height:90%; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
* This event will be held in Japanese only.
The curtailment of medical expenses, the heated discussion on the separation of medicine prescription and dispensation, and the issues of unused medicines and duplicate prescriptions are rising social problems today in Japan. The government had announced to raise the share of generic drug prescriptions to more than80% by fiscal 2020. Ministry of Health, Labor and Welfare will establish the Pharmaceutical Vision by end of year 2015 and revise dispensing fee system in 2016. Now is the time to reconsider the meaning of a pharmacists’ existence.
At this forum, we will be discussing from a private sector perspective on the role that family care pharmacists should play in the narrative of community-based care efforts, promotion of group healthcare and information sharing technology.
We look forward to your participation. Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-fareast-language:ZH-TW;}Registration deadline: 2015-08-10
Exhibition date:2015-08-29
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI